222 related articles for article (PubMed ID: 12296431)
1. Difference in prognostic factors between stage IB and II uterine cervical carcinoma patients treated with radical hysterectomy and postoperative radiation therapy.
Niibe Y; Karasawa K; Kaizu T; Mizutani K; Ozaki Y; Nagano H; Ueda K; Murakami A; Tanaka Y
Radiat Med; 2002; 20(4):161-7. PubMed ID: 12296431
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
3. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
4. Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer.
Okada M; Kigawa J; Minagawa Y; Kanamori Y; Shimada M; Takahashi M; Oishi T; Terakawa N
Gynecol Oncol; 1998 Jul; 70(1):61-4. PubMed ID: 9698475
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.
Kodama J; Seki N; Nakamura K; Hongo A; Hiramatsu Y
Gynecol Oncol; 2007 Jun; 105(3):757-61. PubMed ID: 17433424
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy results for patients undergoing inappropriate surgery in the presence of invasive cervical carcinoma.
Choi DH; Huh SJ; Nam KH
Gynecol Oncol; 1997 Jun; 65(3):506-11. PubMed ID: 9190983
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
9. [The value of adjuvant irradiation in patients with cervical carcinoma in histopathological stage Ib and negative lymph nodes].
Vavra N; Kucera H; Denison U; Salzer H; Schemper M; Sevelda P
Strahlenther Onkol; 1991 Sep; 167(9):509-13. PubMed ID: 1925933
[TBL] [Abstract][Full Text] [Related]
10. Tumor volume and uterine body invasion assessed by MRI for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy.
Kim H; Kim W; Lee M; Song E; Loh JJ
Jpn J Clin Oncol; 2007 Nov; 37(11):858-66. PubMed ID: 18037686
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
12. Radiation injury to intestine following hysterectomy and adjuvant radiotherapy for cervical cancer.
Chen SW; Liang JA; Yang SN; Hung YC; Yeh LS; Shiau AC; Lin FJ
Gynecol Oncol; 2004 Oct; 95(1):208-14. PubMed ID: 15385134
[TBL] [Abstract][Full Text] [Related]
13. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy.
Ho CM; Chien TY; Huang SH; Wu CJ; Shih BY; Chang SC
Gynecol Oncol; 2004 May; 93(2):458-64. PubMed ID: 15099962
[TBL] [Abstract][Full Text] [Related]
15. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
[TBL] [Abstract][Full Text] [Related]
16. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
[TBL] [Abstract][Full Text] [Related]
17. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
[TBL] [Abstract][Full Text] [Related]
18. [Modern tendencies in the treatment of cervical cancer stage IB-IIA, prognostic factors--our and foreign experience].
Ivanov S; Batashki I
Akush Ginekol (Sofiia); 2008; 47(2):38-41. PubMed ID: 18642585
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
[TBL] [Abstract][Full Text] [Related]
20. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma.
Kim JH; Kim HJ; Hong S; Wu HG; Ha SW
Gynecol Oncol; 2005 Feb; 96(2):407-14. PubMed ID: 15661229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
